首页> 外国专利> LDL RECEPTOR MUTANT INDUCING FAMILIAL HYPERCHOLESTEROLEMIA METHOD FOR DETECTING SAME AND PRIMER BEING USEFUL IN SAID METHOD

LDL RECEPTOR MUTANT INDUCING FAMILIAL HYPERCHOLESTEROLEMIA METHOD FOR DETECTING SAME AND PRIMER BEING USEFUL IN SAID METHOD

机译:LDL受体突变诱导家族性胆固醇过高的方法,可用于相同的方法和引物

摘要

PURPOSE: Provided are LDL receptor mutant inducing familial hypercholesterolemia, a method for detecting the same and a primer being useful in the method, therefore the mutant can be effectively used in diagnosis of familial hypercholesterolemia and gene therapy. CONSTITUTION: LDL(low density lipid protein) receptor mutant inducing familial hypercholesterolemia contains a nucleotide sequence selected from: a) a genotype in which 136th nucleotide residue in SEQ ID NO: 1, G is substituted with A; b) a genotype in which nucleotide residues from 363th to 379th in SEQ ID NO: 2 are deleted; c) a genotype in which 15th nucleotide residue in SEQ ID NO: 3, G is substituted with A; d) a genotype in which CTAG are inserted between 134th and 135th nucleotide residues of SEQ ID NO: 4; and e) a genotype in which 116th nucleotide residue of SEQ ID NO: 5, C is substituted with A. A set of primers useful in the method has an amino acid sequence selected from the nucleotide sequences of SEQ ID NOs: 10 and 11, 14 and 15, 20 and 21, 28 and 29, and 34 and 35.
机译:目的:提供了诱导家族性高胆固醇血症的LDL受体突变体,一种检测该突变体的方法和一种可用于该方法的引物,因此该突变体可有效地用于家族性高胆固醇血症的诊断和基因治疗。组成:诱导家族性高胆固醇血症的LDL(低密度脂蛋白)受体突变体包含选自以下的核苷酸序列:a)基因型,其中SEQ ID NO:1中的第136个核苷酸残基,G被A取代; b)基因型,其中删除了SEQ ID NO:2中从第363至379位的核苷酸残基; c)一种基因型,其中SEQ ID NO:3,G中的第15个核苷酸残基被A取代; d)一种基因型,其中CTAG插入在SEQ ID NO:4的第134至135位核苷酸残基之间; e)SEQ ID NO:5,C的第116个核苷酸残基被A取代的基因型。在该方法中有用的一组引物具有选自SEQ ID NO:10和11的核苷酸序列的氨基酸序列。 14和15、20和21、28和29以及34和35。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号